1. Multiple Effects of Berberine Derivatives on Colon Cancer Cells
   Luis Miguel Guamán Ortiz et al, 2014, BioMed Research International CrossRef
2. Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel
   YANYAN HU et al, 2014 CrossRef
3. Human leptin protein activates the growth of HepG2 cells by inhibiting PERK-mediated ER stress and apoptosis
   YING XIONG et al, 2014 CrossRef
4. Synergistic neuroprotective effect of microglial-conditioned media treated with geniposide and ginsenoside Rg1 on hypoxia injured neurons
   JUN WANG et al, 2015 CrossRef
5. Kazinol C from Broussonetia kazinoki activates AMP-activated protein kinase to induce antitumorigenic effects in HT-29 colon cancer cells
   HAK-SU KIM et al, 2015 CrossRef
6. Berberine displays antitumor activity in esophageal cancer cells in vitro
   Shu-Xian Jiang et al, 2017, WJG CrossRef
7. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells
   Yu Kou et al, 2016, Biochemical and Biophysical Research Communications CrossRef
8. Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agents
   Jichao Chen et al, 2017, European Journal of Medicinal Chemistry CrossRef
9. Up-Regulation of PAI-1 and Down-Regulation of uPA Are Involved in Suppression of Invasiveness and Motility of Hepatocellular Carcinoma Cells by a Natural Compound Berberine
   Xuanbin Wang et al, 2016, IJMS CrossRef
10. Cancer Stem Cells: The Potential Targets of Chinese Medicines and Their Active Compounds
    Ming Hong et al, 2016, IJMS CrossRef
11. Anti-hepatocarcinoma effects of berberine nanosuspension against human HepG2 and Huh7 cells as well as H22 tumor bearing mice
    Qingming Luo et al, 2014 CrossRef
12. Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors
    Nabil M. Abdel-Hamid et al, 2018, Biomedicine & Pharmacotherapy CrossRef
13. In vitroandin vivoantitumor efficacy of berberine-nanostructured lipid carriers against H22 tumor
    Wei R. Chen et al, 2015 CrossRef
14. Advances in the study of berberine and its derivatives: a focus on anti-inflammatory and anti-tumor effects in the digestive system
    Kun Zou et al, 2017, Acta Pharmacol Sin CrossRef
15. A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine
    Kuen-Haur Lee et al, 2015, Sci Rep CrossRef
16. Synthesis and Anticancer Activity of Novel 9-O-Substituted Berberine Derivatives
    null Milata et al, 2019, IJMS CrossRef
17. The Role of AMP-Activated Protein Kinase as a Potential Target of Treatment of Hepatocellular Carcinoma
    Xue Jiang et al, 2019, Cancers CrossRef
18. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases
    Zhe Ma et al, 2019, Biomedicine & Pharmacotherapy CrossRef
19. Berberine Ameliorates Collagen-Induced Arthritis in Rats Associated with Anti-inflammatory and Anti-angiogenic Effects
    Zhigang Wang et al, 2014, Inflammation CrossRef
20. FoxO proteins’ nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells
    Shatrunajay Shukla et al, 2014, Free Radical Biology and Medicine CrossRef
21. Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway
    Xuan Liu et al, 2015, PLoS ONE CrossRef
22. Determination of cytotoxicity of traditional Chinese medicine herbs, Rhizoma coptidis, Radix scutellariae, and Cortex phellodendri, by three methods
    Maureen Boost et al, 2016, Contact Lens and Anterior Eye CrossRef
23. Functional Cross-Talking between Differentially Expressed and Alternatively Spliced Genes in Human Liver Cancer Cells Treated with Berberine
    Zhen Sheng et al, 2015, PLoS ONE CrossRef
24. Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma.
    Caiyan Liu et al, 2019, Biomed Pharmacother CrossRef
25. A combination of Citrus reticulata peel and black tea inhibits migration and invasion of liver cancer via PI3K/AKT and MMPs signaling pathway
    Shuai Wen et al, 2019, Mol Biol Rep CrossRef
26. Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
    Chaohe Zhang et al, 2020, Front. Pharmacol. CrossRef
27. Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1
    Chunming Gu et al, 2020, BMC Biol CrossRef
28. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases
    Haoran Wang et al, 2018, Oncotarget CrossRef
29. Berberine can amplify cytotoxic effect of radiotherapy by targeting cancer stem cells
    Sanaa A El-Benhawy et al, 2020, Breast Cancer Management CrossRef
30. Potentiating the activity of berberine for Staphylococcus aureus in a combinatorial treatment with thymol
    Cemile Selin Aksoy et al, 2020, Microbial Pathogenesis CrossRef
31. Effect of Berberine Associated with Photodynamic Therapy in Cell Lines
    P.M. Oliveira et al, 2020, Photodiagnosis and Photodynamic Therapy CrossRef
32. Anti-cancer properties of specific Chinese herbal medicines for hepatocellular carcinoma treatment
    Zang Ping et al, 2020, European Journal of Integrative Medicine CrossRef
33. The pharmacological activity of berberine, a review for liver protection
    Mengting Zhou et al, 2020, European Journal of Pharmacology CrossRef
34. In Vitro Anticancer Potential of Berberis lycium Royle Extracts against Human Hepatocarcinoma (HepG2) Cells
    Kiren Mustafa et al, 2020, BioMed Research International CrossRef
35. Nanotechnology-Based Strategies for Berberine Delivery System in Cancer Treatment: Pulling Strings to Keep Berberine in Power
    Muhammad Javed Iqbal et al, 2021, Front. Mol. Biosci. CrossRef
36. Anticancer Potential of Natural Isoquinoline Alkaloid Berberine
    Ganesh C. Jagetia, 2021 CrossRef
37. Probing Synergistic Targets by Natural Compounds for Hepatocellular Carcinoma
    Jian Gao et al, 2021, Front. Cell Dev. Biol. CrossRef
38. Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m6A Methylation
    Ziyi Zhao et al, 2021, Front. Oncol. CrossRef
39. Protective effects of plant-derived natural products against hepatocellular carcinoma
    Meenakshi Gupta et al, 2022 CrossRef
40. Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma
    Chuting Li et al, 2022, Funct Integr Genomics CrossRef
41. Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
    Bahram Bibak et al, 2022, CMC CrossRef
42. Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma model
    Gang Ren et al, 2022, Molecular Therapy - Oncolytics CrossRef
43. Development of novel 9-O-substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents
    Jichao Chen et al, 2022, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
44. Targeted Pyroptosis Is a Potential Therapeutic Strategy for Cancer
    Hao Wu et al, 2022, Journal of Oncology CrossRef
45. Design, synthesis and biological evaluation of novel 9-N-substituted-13-alkylberberine derivatives from Chinese medicine as anti-hepatocellular carcinoma agents
    Jichao Chen et al, 2023, Bioorganic & Medicinal Chemistry CrossRef
46. The therapeutic effects of berberine for gastrointestinal cancers
    Amirhossein Davoodvandi et al, 2023, Asia-Pac J Clncl Oncology CrossRef
47. Current understanding and future prospects on Berberine for anticancer therapy
    Anjana Goel, 2023, Chem Biol Drug Des CrossRef
48. The place of berberine in the treatment of metabolic syndrome
    E. V. Shrayner et al, 2024, jour CrossRef
49. The Potential of the Nutraceutical Berberine in the Treatment of Hepatocellular Carcinoma and other Liver Diseases such as NAFLD and NASH.
    Melchiorre Cervello et al, 2024, Advances in Biological Regulation CrossRef
50. Antioxidant and Cytotoxic Properties of Berberis vulgaris (L.) Stem Bark Dry Extract
    Ionuț Mădălin Ivan et al, 2024, Molecules CrossRef
51. Carrier-Free Self-Assembled Nanomedicines for Promoting Apoptosis and Inhibiting Proliferation in Hepatocellular Carcinoma
    WeiLu Jia et al, 2024, ACS Biomater. Sci. Eng. CrossRef
52. Research progress on pharmacological effects and bioavailability of berberine
    Yulong Cui et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
53. Berberine as a Potential Anticancer Agent: A Comprehensive Review
    Abdur Rauf et al, 2021, Molecules CrossRef
54. Phytochemicals regulate cancer metabolism through modulation of the AMPK/PGC-1α signaling pathway
    Sajad Fakhri et al, 2024, BMC Cancer CrossRef
55. Effects of Berberine on Liver Cancer
    Yiting Liu et al, 2022, Natural Product Communications CrossRef
56. Transplant oncology and anti-cancer immunosuppressants
    Dejun Kong et al, 2025, Front. Immunol. CrossRef